1. A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Issue 25 (27th May 2016) Authors: Falloon, Judith; Ji, Fei; Curtis, Craig; Bart, Stephan; Sheldon, Eric; Krieger, Diane; Dubovsky, Filip; Lambert, Stacie; Takas, Therese; Villafana, Tonya; Esser, Mark T. Journal: Vaccine Issue: Volume 34:Issue 25(2016) Page Start: 2847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗